AstraZeneca's US Drug-Price Deal Sparks Uncertainty

On this episode of Stock Movers:
- LLoyds is up despite saying it intends to set aside an extra £800m in compensation for motor finance claims.
- Big Yellow Group shares have jumped on reports that Blackstone is weighing a bid for the UK self-storage firm.
_ AstraZeneca is down on in its initial rebound after a deal with the Trump administration to lower drug prices in the US in exchange for tariff relief.

See omnystudio.com/listener for privacy information.